Glaucoma drug Lumigan (bimatoprost) has been rebadged as Latisse. I’ve talked about the development of bimatoprost into a cosmetic product here in the past.
Latisse joins Botox, Lap-Band, Natrelle breast implants, and collagen injections and implants, in Allergan’s fleecing-women stable of products. No matter what part of your body the Patriarchy has made you feel insecure about, if you have heaps of time, pots of cash, and a devil-may-care attitude to the potential for adverse effects, Allergan has something you can brush on, inject, or implant in the hope that bodily adjustments will buy you happiness. Advertised results not typical. Standard disclaimers apply.
I set out to write a long post, but ended up throwing up my hands wondering what the fucking point is. If you think you have a disease called “breast ptosis“, you probably also think you have a disease called “hypotrichosis of the eyelashes“, to the dreadful degree that this poor unfortunate soul has it. And don’t ask me how her eyebrow changed colour too. It’s the same woman, they swear. No Photoshop, either. I do feel sorry for that inflamed-looking eyelid margin, though.
So go crazy. It’s only $120 a month, around four times the cost of the glaucoma treatment of the same drug in the same concentration, but you get dinky little eyelash brushes with it. Side effects include itching, reddening of the eyes, growth of hair in other places the brush has touched, skin darkening, irreversible brown pigmentation of the irises, oedema of the macula (central part of the retina), cataracts, armpit homunculus, autonomous nipple, and involuntary Narnia adventures. With apologies to Stephen Colbert.
[Note: this may be of use for those with alopecia totalis/cicatricial alopecia. This is not, however, how it’s being marketed. And I see no reason why those people should pay the 300% cosmetic markup.]